Haemonetics Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Haemonetics Corp 公司

Haemonetics Corporation 是一家全球醫療保健公司。該公司致力於爲客戶提供一系列醫療產品和解決方案，幫助他們改善患者護理並降低醫療保健成本。該公司的技術適用於各種醫療市場，包括血液和血漿成分採集、手術室和醫院輸血服務。該公司的血漿部門包括血漿採集設備和一次性用品、捐贈者管理軟件和銷售給血漿客戶的支持軟件解決方案。其血液中心部門製造併爲客戶提供全系列的自動血液採集單採解決方案。該公司的醫院部門包括介入技術，包括血管閉合、傳感器引導技術和食管保護產品，以及血液管理技術，包括止血管理、細胞回收和輸血管理產品。

公司簡介

公司代碼HAE

公司名稱Haemonetics Corp

上市日期Oct 17, 1979

CEOMr. Christopher A. Simon

員工數量3023

證券類型Ordinary Share

年結日Oct 17

公司地址125 Summer Street

城市BOSTON

上市交易所NYSE Consolidated

國家United States of America

郵編02110

電話17818487100

網址https://www.haemonetics.com

公司代碼HAE

上市日期Oct 17, 1979

CEOMr. Christopher A. Simon

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.24K

+12.76%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

23.36K

+13.03%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

Mr. Michael J. Coyle

Independent Director

15.39K

+21.20%

Ms. Diane M. Bryant

Independent Director

7.13K

+60.75%

Mr. Roy Galvin

Executive Vice President, Chief Commercial Officer

3.39K

--

Mr. Frank W. Chan

Chief Operating Officer, Executive Vice President

--

名稱

名稱/職務

職務

持股

持股變動

Ms. Laurie A. Miller

Chief Human Resources Officer, Senior Vice President

28.24K

+12.76%

Mr. Charles J. Dockendorff, CPA

Independent Director

25.04K

+12.05%

Mr. Robert E. Abernathy

Independent Director

24.98K

+12.08%

Dr. Mark W. Kroll, Ph.D.

Independent Director

23.36K

+13.03%

Ms. Michelle L. Basil, J.D.

Executive Vice President, General Counsel

19.69K

+2.11%

Ms. Ellen M. Zane

Independent Chairman of the Board

19.37K

+16.15%

收入明細

單位: USD更新時間: 7月6日週日

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

暫無數據

地區USD

名稱

營收

佔比

United States

1.01B

74.29%

Europe

175.66M

12.91%

Asia

92.31M

6.78%

Japan

62.41M

4.59%

other

19.54M

1.44%

業務

地區

暫無數據

股東統計

更新時間: 8月27日週三

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.56%

The Vanguard Group, Inc.

10.26%

Neuberger Berman, LLC

8.88%

Wellington Management Company, LLP

4.46%

State Street Global Advisors (US)

3.91%

其他

60.94%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

11.56%

The Vanguard Group, Inc.

10.26%

Neuberger Berman, LLC

8.88%

Wellington Management Company, LLP

4.46%

State Street Global Advisors (US)

3.91%

其他

60.94%

股東類型

持股股東

佔比

Investment Advisor

52.55%

Investment Advisor/Hedge Fund

49.82%

Hedge Fund

5.32%

Research Firm

4.12%

Bank and Trust

1.39%

Pension Fund

1.35%

Individual Investor

1.19%

Sovereign Wealth Fund

1.11%

Insurance Company

0.04%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

700

57.31M

118.95%

-4.19M

2025Q1

723

57.94M

120.44%

-3.07M

2024Q4

701

58.48M

116.40%

-1.44M

2024Q3

689

57.60M

112.60%

-1.51M

2024Q2

668

57.60M

113.31%

+3.07M

2024Q1

655

52.49M

103.35%

-1.26M

2023Q4

647

51.85M

102.19%

-3.31M

2023Q3

657

52.00M

102.54%

-4.11M

2023Q2

656

51.75M

102.38%

-4.68M

2023Q1

715

51.58M

102.24%

-8.44M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.67M

11.79%

+31.09K

+0.55%

Mar 31, 2025

The Vanguard Group, Inc.

5.09M

10.59%

-80.50K

-1.56%

Mar 31, 2025

Neuberger Berman, LLC

4.35M

9.05%

-70.98K

-1.61%

Mar 31, 2025

Wellington Management Company, LLP

2.62M

5.46%

-1.32M

-33.38%

Mar 31, 2025

State Street Global Advisors (US)

1.92M

3.99%

-28.97K

-1.49%

Mar 31, 2025

River Road Asset Management, LLC

1.40M

2.9%

+1.04M

+295.76%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

2.20M

4.57%

-358.25K

-14.03%

Mar 31, 2025

Royce Investment Partners

1.16M

2.42%

+8.03K

+0.70%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.22M

2.54%

+40.32K

+3.41%

Mar 31, 2025

Capital Research Global Investors

1.58M

3.28%

-2.66M

-62.79%

Mar 31, 2025

持股ETF

更新時間: 9月6日週六

機構名稱

佔比

Harbor Human Capital Factor US Small Cap ETF

1.78%

SPDR S&P Health Care Equipment ETF

1.45%

First Trust Small Cap Growth AlphaDEX Fund

0.28%

Fidelity Small-Mid Multifactor ETF

0.15%

Global X Russell 2000 ETF

0.15%

Vanguard S&P Mid-Cap 400 Growth Index Fund

0.14%

Invesco Dynamic Buyback Achievers ETF

0.12%

Nuveen ESG Small-Cap ETF

0.11%

Vanguard S&P Mid-Cap 400 Value Index Fund

0.11%

SPDR S&P 400 Mid Cap Growth ETF

0.1%

Harbor Human Capital Factor US Small Cap ETF

佔比1.78%

SPDR S&P Health Care Equipment ETF

佔比1.45%

First Trust Small Cap Growth AlphaDEX Fund

佔比0.28%

Fidelity Small-Mid Multifactor ETF

佔比0.15%

Global X Russell 2000 ETF

佔比0.15%

Vanguard S&P Mid-Cap 400 Growth Index Fund

佔比0.14%

Invesco Dynamic Buyback Achievers ETF

佔比0.12%

Nuveen ESG Small-Cap ETF

佔比0.11%

Vanguard S&P Mid-Cap 400 Value Index Fund

佔比0.11%

SPDR S&P 400 Mid Cap Growth ETF

佔比0.1%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Haemonetics Corp

50.600USD

Haemonetics Corp

50.600

概覽

公司

財務

分析